Exhibiting at VIV Asia 2025

Biogénesis Bagó: Innovating Animal Health Through Biotechnology

About Biogénesis Bagó

Biogénesis Bagó is a leading biotechnology company specializing in animal health solutions. Headquartered in Buenos Aires, Argentina, the company is renowned for developing cutting-edge vaccines, pharmaceuticals, and reproductive health products for the livestock industry. With a strong presence in Latin America, Asia, and North America, Biogénesis Bagó plays a pivotal role in global food security by ensuring healthier livestock and higher production efficiency.

Core Business and Market Positioning

Biogénesis Bagó operates at the intersection of biotechnology and animal health, offering solutions for disease prevention, treatment, and nutritional enhancement in livestock. The company is particularly recognized for its expertise in foot-and-mouth disease (FMD) vaccines, being one of the global leaders in FMD prevention and eradication programs.

Product and Service Offerings

Vaccines

• Foot-and-Mouth Disease Vaccine – One of the most widely used vaccines in FMD control programs globally.
• Rabies Vaccine – Protects cattle, horses, and companion animals from rabies infection.

Pharmaceuticals

• Antibiotics – Solutions for bacterial infections in livestock.
• Ectoparasiticides & Endoparasiticides – Protect against external and internal parasites.
• Endectocides – Effective against both internal and external parasites, improving animal health.

Nutraceuticals

• Vitamins & Minerals – Essential for maintaining animal productivity, immunity, and reproductive health.

Reproductive Health

• Hormonal Products – Enhance fertility rates and reproductive performance in cattle, swine, and equine species.

Research & Development Leadership

Biogénesis Bagó has state-of-the-art R&D facilities dedicated to vaccine innovation, biopharmaceutical research, and disease prevention solutions. The company collaborates with global veterinary organizations and research institutes to develop next-generation solutions for emerging livestock diseases.

Financial Performance & Market Expansion

Biogénesis Bagó has demonstrated consistent revenue growth, attributed to its expansion into international markets and technological advancements. The company exports its products to over 50 countries, with a strong footprint in Latin America, Asia, and North America.

International Shipments & Market Expansion

• The company has multiple manufacturing sites that comply with international veterinary and pharmaceutical regulations.
• Strategic partnerships with China, Southeast Asia, and the United States have strengthened its position in the global veterinary health market.
• Biogénesis Bagó has been a key contributor to global foot-and-mouth disease eradication programs, with large-scale vaccine production facilities.

Certifications & Compliance

Biogénesis Bagó meets international veterinary pharmaceutical regulations, ensuring product safety and efficacy. The company holds:

• Good Manufacturing Practices (GMP) certification
• World Organization for Animal Health (WOAH) accreditation for FMD vaccine production
• Regulatory approvals in Latin America, Asia, and North America

Customer Testimonials & Industry Recognition

• Recognized by global livestock producers for its role in controlling and eradicating foot-and-mouth disease.
• Positive feedback from veterinarians and farmers on the effectiveness of its vaccines and pharmaceuticals.
• Awarded for its contributions to animal health innovation and sustainable livestock management.

Major Achievements

• One of the world’s largest FMD vaccine producers.
• Presence in 50+ countries worldwide.
• Pioneered advanced biotechnology solutions for livestock health.
• Established research collaborations with global veterinary organizations.

Biogénesis Bagó remains at the forefront of biotechnology-driven animal health solutions, contributing to sustainable and efficient livestock production on a global scale.